Anti-rheumatic and Memory-enhancing Effect of Memantine on Complete Freund’s Adjuvant-induced Rheumatoid Arthritis Compared to Methotrexate in Wistar Rats

ABSTRACT

Objectives: To evaluate the anti-inflammatory and memory-enhancing effects of memantine (MEM) in complete Freund’s adjuvant (CFA)-induced rheumatoid arthritis (RA) in Wistar rats. The effect of MEM on cognition in CFA-induced RA was also evaluated. Materials and Methods: The rats were randomly assigned to one of five groups: sham control (SC), disease control (DC)—CFA 0.1 mg, positive control (PC)—methotrexate (MTX) 1 mg/kg, low dose MEM—20 mg/kg, and high dose MEM (HD-M)—50 mg/kg. All groups received a subcutaneous injection of CFA in the left paw on day 0, except for the SC group, which received a distilled water (DW) injection. The study drugs, MEM and MTX, were administered orally from days 15 to 28. The SC group received DW orally from days 15 to 28. Variables for physical (paw volume, paw surface temperature, and ankle joint diameter) and behavior (open field test, grip strength test, and water corn test) were performed on days 1, 0, 7, 14, 21, and 28. On day 28, blood was collected for serum inflammatory markers, tumor necrosis factor-alpha (TNF-α) and interleukin (IL)-6. Ex vivo radiological changes in the ankle joint were recorded using a digitalized X-ray machine. Histopathology of the ankle joint was performed. Results: When compared to the DC group, the HD-M group showed a significant improvement in all physical and behavioral characteristics (p < 0.001). When compared to the DC group, TNF-α, IL-6 levels, and histopathological scores were significantly lower in the HD-M group (p < 0.01). Conclusion: MEM reduces inflammation and improves memory in Wistar rats with CFA-induced RA. MEM can be used as an anti-inflammatory drug in elderly patients at risk of dementia.

KEYWORDS

• Grip strength
• IL-6
• rheumatoid arthritis
• TNF-α

Showing references and in-text citations exactly as published.

Cite this article

• DOI10.1177/0976500X231211394Copy

RELATED ARTICLES

Matched on section and article type within this issue of J Pharmacol. Pharmacother..

• Article · VOLUME 14, ISSUE 3Moringa oleifera Modulates MPTP-induced Mitochondrial Dysfunction in Parkinson’s Mouse Model: An in silico and in vivo AnalysisSmriti Singh, Priyanka Kumari Keshri, Vijaya Nath Mishra, Surya Pratap Singh · pp. 187–200Research ArticleSame type: Article
• Article · VOLUME 14, ISSUE 3A Study to Evaluate the Efficacy of Saroglitazar in Non-Alcoholic Steatohepatitis Induced by High Fructose Diet Rat ModelSaravanan T., Shanmugapriya S., Eliz Thomas, Karthika P. · pp. 201–209Research ArticleSame type: Article
• Article · VOLUME 14, ISSUE 3Cost-effectiveness and Side Effects of Using Heparin and Enoxaparin as a Treatment for COVID-19-associated CoagulopathyNurul Iska Ulmarika Idris, Abdul Khairul Rizki Purba, Arifa Mustika, Anna Surgean Veterini, Mochamad Yusuf Alsagaff, Mohammad Qorib · pp. 220–230Research ArticleSame type: Article
• Article · VOLUME 14, ISSUE 3Effect of Fluoxetine and Escitalopram on Heart Rate Variability (HRV) and Serum Potassium Level in Patients of Depression and Anxiety DisordersTruptiben R Machhi, Chetna R. Patel, Sajal K. Pandya, N. D. Kantharia · pp. 231–237Research ArticleSame type: Article